⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

October 1, 2024

Figure S10 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER⁺ Breast Cancer

Anran Chen Beom-Jun Kim Aparna Mitra Craig T. Vollert Jonathan T. Lei Diana Fandino Meenakshi Anurag Matthew V. Holt Xuxu Gou Jacob B. Pilcher Matthew P. Goetz Donald W. Northfelt Susan G. Hilsenbeck C. Gary Marshall Marc L. Hyer Robert Papp Shou-Yun Yin Carmine De Angelis Rachel Schiff Suzanne A.W. Fuqua X. Cynthia Charles E. Foulds Matthew J. Ellis

View Full Paper

Ask AI

Bookmark

Share

Abstract

PKMYT1 mRNA significantly correlates with Ki67 mRNA in Luminal A and B breast cancer samples from the METABRIC cohort

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chen et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efef48 https://doi.org/10.1158/1535-7163.27142279

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S4 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
2Figure S6 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
3Figure S2 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
4Figure S5 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024
5Table S5 from PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER<sup>+</sup> Breast Cancer2024